2024最新薑黃素推薦指南！5 大選購要點、10 款優質產品一次

Atezolizumab FDA | 合法醫療器材資訊網

Atezolizumab FDA

FDAapprovesatezolizumabforfirst-linetreatmentofmetastaticNSCLCwithhigh...OnMay18,2020,theFoodandDrugAdministrationapprovedatezolizumab ...,FDAapprovesatezolizumabforPD-L1positiveunresectablelocallyadvancedor...OnMarch8,2019,theFoodandDrugAdministrationgrantedaccelerated ...,2020年6月1日—FDAapprovesatezolizumabplusbevacizumabforunresectablehepatocellularcarcinoma...OnMay29,2020,theFoodandDrugAdministration ...,2021年1月28日—TecentriqFDAApprovalHistory·UrothelialCarcinoma.Tecentriqisindicatedf...

Atezolizumab atezolizumab仿單 Atezolizumab FDA Atezolizumab/bevacizumab HCC FDA Atezolizumab Roche Atezolizumab package insert 2020 Avelumab Atezolizumab wiki Atezolizumab atezolizumab仿單 Atezolizumab FDA Atezolizumab/bevacizumab HCC FDA Atezolizumab Roche Atezolizumab package insert 2020 Avelumab Atezolizumab wiki Nivolumab package insert 2020 Nivolumab package insert 2021 Pembrolizumab package insert Avastin package insert Durvalumab package insert YERVOY package insert Pembrolizumab label Durvalumab atezolizumab副作用 atezolizumab中文 IMbrave150 Pembrolizumab Atezolizumab bevacizumab Atezolizumab bevacizumab HCC FDA Atezolizumab Avastin imbrave150 Nejm atezolizumab Atezolizumab melanoma IMbrave150 pdf 貼立舒 Csd EXAMINATION GLOVES (Sterile/Non-Sterile) 鼻導管給氧 Nasal cannula 慶盛儀器有限公司 喜樂 雷 射 高雄 GAIA 公司 皰疹檢驗
FDA approves atezolizumab for first | 合法醫療器材資訊網
FDA approves atezolizumab for first-line treatment of metastatic NSCLC with high ... On May 18, 2020, the Food and Drug Administration approved atezolizumab ... Read More
FDA approves atezolizumab for PD | 合法醫療器材資訊網
FDA approves atezolizumab for PD-L1 positive unresectable locally advanced or ... On March 8, 2019, the Food and Drug Administration granted accelerated ... Read More
FDA approves atezolizumab plus bevacizumab for ... | 合法醫療器材資訊網
2020年6月1日 — FDA approves atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma ... On May 29, 2020, the Food and Drug Administration ... Read More
Tecentriq (atezolizumab) FDA Approval History | 合法醫療器材資訊網
2021年1月28日 — Tecentriq FDA Approval History · Urothelial Carcinoma. Tecentriq is indicated for the treatment of adult patients with locally advanced or metastatic ... Read More
TECENTRIQ (atezolizumab) | 合法醫療器材資訊網
Patients with EGFR or ALK genomic tumor aberrations should have disease progression on FDA- approved therapy for NSCLC harboring these aberrations prior ... Read More
Label (PDF) | 合法醫療器材資訊網
TECENTRIQ. TECENTRIQ® (atezolizumab) injection, for intravenous use ... should have disease progression on FDA-approved therapy for NSCLC harboring ... Read More
Atezolizumab | 合法醫療器材資訊網
In October 2016, atezolizumab was approved by the FDA for the treatment of people with metastatic non-small cell lung cancer (NSCLC) whose disease ... Read More
相關資訊整理

【羅氏凡塔那抗ALK(D5F3)兔子單株抗體】許可證字號:衛部醫器輸字第025531號

器材品名:羅氏凡塔那抗ALK(D5F3)兔子單株抗體許可證字號:衛部醫器輸字第025531號註銷狀態:註銷日期:註銷理由:有效日期:2023/...

【羅氏抗PD-L1 (SP142) 兔單株一級抗體檢驗試劑】許可證字號:衛部醫器輸字第033118號

器材品名:羅氏抗PD-L1(SP142)兔單株一級抗體檢驗試劑許可證字號:衛部醫器輸字第033118號註銷狀態:註銷日期:註銷理由:有效日...

【達克HER2螢光原位雜交檢測套組】許可證字號:衛部醫器輸字第032407號

器材品名:達克HER2螢光原位雜交檢測套組許可證字號:衛部醫器輸字第032407號註銷狀態:註銷日期:註銷理由:有效日期:2024/04/15...

【"羅氏" 凡塔那PD-L1 (SP142) 單株抗體 (未滅菌)】許可證字號:衛部醫器輸壹字第017939號

器材品名:"羅氏"凡塔那PD-L1(SP142)單株抗體(未滅菌)許可證字號:衛部醫器輸壹字第017939號註銷狀態:註銷日期:註銷理由:有效...

【羅氏凡塔那ALK二合一品管玻片】許可證字號:衛部醫器輸字第025267號

器材品名:羅氏凡塔那ALK二合一品管玻片許可證字號:衛部醫器輸字第025267號註銷狀態:註銷日期:註銷理由:有效日期:2023/08/20...

【“達克” PD-L1免疫組織化學染色22C3檢測套組】許可證字號:衛部醫器輸字第028961號

器材品名:“達克”PD-L1免疫組織化學染色22C3檢測套組許可證字號:衛部醫器輸字第028961號註銷狀態:註銷日期:註銷理由:有效日期...

【羅氏凡塔那PD-L1(SP142)檢驗試劑】許可證字號:衛部醫器輸字第029845號

器材品名:羅氏凡塔那PD-L1(SP142)檢驗試劑許可證字號:衛部醫器輸字第029845號註銷狀態:註銷日期:註銷理由:有效日期:2022/09/...

【羅氏人類上皮因子接受體第2蛋白兔子單株抗體】許可證字號:衛部醫器輸字第027542號

器材品名:羅氏人類上皮因子接受體第2蛋白兔子單株抗體許可證字號:衛部醫器輸字第027542號註銷狀態:註銷日期:註銷理由:有效日...